Top experts by indication / Oncology
Most active experts in Ovarian / Gynecologic Cancer
2026 edition, data as of October 26, 2026
427 key opinion leaders in the directory are tagged to Ovarian / Gynecologic Cancer. The tables below rank them by one public measure each: registered trials, citations, NIH awards and congress contributions. Each is a count from a named source, not a judgment about the person, and every row links a profile where the count can be checked.
Most registered trials
Registered clinical trials in this indication on which the person is a listed investigator, counted from ClinicalTrials.gov. 358 of the 427 people tagged to this indication have this count on record; the 25 highest are listed. Source: ClinicalTrials.gov.
| # | Expert | trials |
|---|---|---|
| 1 | Kathleen MooreUniversity of Nebraska Medical Center, OK | 15 trials |
| 2 | Melissa GellerUniversity of Minnesota Medical School, MN | 15 trials |
| 3 | Angeles SecordDuke University School of Medicine, NC | 14 trials |
| 4 | Bradley MonkFlorida Cancer Specialists & Research Institute, FL | 13 trials |
| 5 | Premal ThakerWashington University School of Medicine in St. Louis, MO | 13 trials |
| 6 | Amir JazaeriThe University of Texas MD Anderson Cancer Center, TX | 11 trials |
| 7 | Jun ZhangIA | 10 trials |
| 8 | Ursula MatulonisDana-Farber Cancer Institute, MA | 10 trials |
| 9 | David MillerUT Southwestern Medical Center, TX | 9 trials |
| 10 | Daniela MateiHouston Methodist Dr. Mary and Ron Neal Cancer Center, IL | 9 trials |
| 11 | Kathleen SchmelerThe University of Texas MD Anderson Cancer Center, TX | 9 trials |
| 12 | Robert BurgerPA | 8 trials |
| 13 | Russell SchilderThomas Jefferson University, PA | 8 trials |
| 14 | Rebecca ArendUniversity of Alabama at Birmingham, AL | 8 trials |
| 15 | Don DizonTufts Medicine, RI | 8 trials |
| 16 | Linda DuskaUniversity of Virginia Health System, VA | 8 trials |
| 17 | Levi DownsMN | 7 trials |
| 18 | Stephanie GaillardJohns Hopkins University School of Medicine, MD | 7 trials |
| 19 | Richard PensonMassachusetts General Hospital, MA | 7 trials |
| 20 | Emese ZsirosRoswell Park Comprehensive Cancer Center, NY | 7 trials |
| 21 | Alessandro SantinYale School of Medicine, CT | 7 trials |
| 22 | Claire VerschraegenThe Ohio State University, OH | 7 trials |
| 23 | Robert WenhamMoffitt Cancer Center, FL | 7 trials |
| 24 | Alexander SpiraVirginia Cancer Specialists, VA | 6 trials |
| 25 | Frederick UelandUniversity of Kentucky, KY | 6 trials |
Most cited
Citations to the person's whole published record in OpenAlex, not only their work in this indication, among the people with at least two registered trials in it. 90 of the 427 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: OpenAlex.
| # | Expert | citations |
|---|---|---|
| 1 | Robert MotzerMemorial Sloan Kettering Cancer Center, NY | 124,725 citations |
| 2 | Razelle KurzrockMedical College of Wisconsin, WI | 88,610 citations |
| 3 | Elizabeth SwisherUniversity of Washington, WA | 67,678 citations |
| 4 | Scott KopetzThe University of Texas MD Anderson Cancer Center, TX | 59,091 citations |
| 5 | Robert ColemanVaniam Group, TX | 53,393 citations |
| 6 | Naoto UenoUniversity of Hawaiʻi Cancer Center, HI | 49,693 citations |
| 7 | David HongThe University of Texas MD Anderson Cancer Center, TX | 47,734 citations |
| 8 | Kathleen MooreUniversity of Nebraska Medical Center, OK | 47,487 citations |
| 9 | Bradley MonkFlorida Cancer Specialists & Research Institute, FL | 45,442 citations |
| 10 | Ursula MatulonisDana-Farber Cancer Institute, MA | 45,219 citations |
| 11 | David GershensonThe University of Texas MD Anderson Cancer Center, TX | 44,753 citations |
| 12 | Lois RamondettaThe University of Texas MD Anderson Cancer Center, TX | 43,689 citations |
| 13 | Mark PegramStanford University School of Medicine, CA | 41,838 citations |
| 14 | Angeles SecordDuke University School of Medicine, NC | 41,092 citations |
| 15 | John GlaspyUniversity of California, Los Angeles, CA | 38,724 citations |
| 16 | Jonathan BerekStanford University School of Medicine, CA | 37,420 citations |
| 17 | Carol AghajanianMemorial Sloan Kettering Cancer Center, NY | 36,523 citations |
| 18 | Alexander SpiraVirginia Cancer Specialists, VA | 29,600 citations |
| 19 | Michael MorseDuke University School of Medicine, NC | 28,410 citations |
| 20 | James GulleyNational Cancer Institute, MD | 28,235 citations |
| 21 | Timothy YapThe University of Texas MD Anderson Cancer Center, TX | 27,287 citations |
| 22 | Cathy EngVanderbilt University Medical Center, TN | 26,943 citations |
| 23 | Patrick StiffLoyola University Medical Center, IL | 26,668 citations |
| 24 | Michael GoldGold Skin Care Center, TN | 25,864 citations |
| 25 | Richard PensonMassachusetts General Hospital, MA | 24,598 citations |
Most NIH awards
NIH awards on the person's record in NIH RePORTER, across all of their funded work, among the people with at least two registered trials in this indication. 81 of the 427 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: NIH RePORTER.
| # | Expert | awards |
|---|---|---|
| 1 | Mary DisisWA | 23 awards |
| 2 | Scott KopetzThe University of Texas MD Anderson Cancer Center, TX | 13 awards |
| 3 | James FordCA | 11 awards |
| 4 | Daniela MateiHouston Methodist Dr. Mary and Ron Neal Cancer Center, IL | 9 awards |
| 5 | Elizabeth SwisherUniversity of Washington, WA | 8 awards |
| 6 | George CoukosPA | 7 awards |
| 7 | Kathleen SchmelerThe University of Texas MD Anderson Cancer Center, TX | 7 awards |
| 8 | David AviganDana-Farber Cancer Institute, MA | 7 awards |
| 9 | Kathleen MooreUniversity of Nebraska Medical Center, OK | 6 awards |
| 10 | Pamela MunsterStanford University School of Medicine, CA | 6 awards |
| 11 | Alexi WrightDana-Farber Cancer Institute, MA | 6 awards |
| 12 | Michele FollenTX | 5 awards |
| 13 | John GlaspyUniversity of California, Los Angeles, CA | 5 awards |
| 14 | Claire VerschraegenThe Ohio State University, OH | 5 awards |
| 15 | Naoto UenoUniversity of Hawaiʻi Cancer Center, HI | 4 awards |
| 16 | Deborah ArmstrongMD | 4 awards |
| 17 | Joan WalkerUniversity of Oklahoma Health Sciences Center, OK | 4 awards |
| 18 | David MutchMO | 4 awards |
| 19 | David HongThe University of Texas MD Anderson Cancer Center, TX | 4 awards |
| 20 | Jonathan BerekStanford University School of Medicine, CA | 4 awards |
| 21 | Angeles SecordDuke University School of Medicine, NC | 4 awards |
| 22 | Ruby MeredithAL | 3 awards |
| 23 | Stephen CannistraBeth Israel Deaconess Medical Center, MA | 3 awards |
| 24 | Tyler CurielDartmouth College, NH | 3 awards |
| 25 | Matthew BlockMN | 3 awards |
Most congress contributions
Congress abstracts and presentations attributed to the person and verified by DOI, across every meeting the directory tracks, among the people with at least two registered trials in this indication. 42 of the 427 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: Congress abstracts, DOI-verified.
| # | Expert | contributions |
|---|---|---|
| 1 | Erika HamiltonSarah Cannon Research Institute, TN | 364 contributions |
| 2 | James GulleyNational Cancer Institute, MD | 255 contributions |
| 3 | Siqing FuThe University of Texas MD Anderson Cancer Center, TX | 241 contributions |
| 4 | Cathy EngVanderbilt University Medical Center, TN | 240 contributions |
| 5 | Timothy YapThe University of Texas MD Anderson Cancer Center, TX | 221 contributions |
| 6 | Ursula MatulonisDana-Farber Cancer Institute, MA | 195 contributions |
| 7 | Pamela MunsterStanford University School of Medicine, CA | 180 contributions |
| 8 | Minal BarveMary Crowley Cancer Research, TX | 139 contributions |
| 9 | Mark PegramStanford University School of Medicine, CA | 122 contributions |
| 10 | Michael MorseDuke University School of Medicine, NC | 114 contributions |
| 11 | Jennifer SpechtFred Hutchinson Cancer Center, WA | 104 contributions |
| 12 | Daniela MateiHouston Methodist Dr. Mary and Ron Neal Cancer Center, IL | 92 contributions |
| 13 | Claire VerschraegenThe Ohio State University, OH | 90 contributions |
| 14 | Amir JazaeriThe University of Texas MD Anderson Cancer Center, TX | 87 contributions |
| 15 | Antoinette TanWake Forest School of Medicine, NC | 82 contributions |
| 16 | John GlaspyUniversity of California, Los Angeles, CA | 81 contributions |
| 17 | Premal ThakerWashington University School of Medicine in St. Louis, MO | 80 contributions |
| 18 | Rebecca ArendUniversity of Alabama at Birmingham, AL | 75 contributions |
| 19 | Angeles SecordDuke University School of Medicine, NC | 75 contributions |
| 20 | David AviganDana-Farber Cancer Institute, MA | 74 contributions |
| 21 | Alexi WrightDana-Farber Cancer Institute, MA | 70 contributions |
| 22 | Sharad GhamandeMedical College of Georgia at Augusta University, GA | 61 contributions |
| 23 | Alessandro SantinYale School of Medicine, CT | 60 contributions |
| 24 | Martee HensleyMemorial Sloan Kettering Cancer Center, NY | 60 contributions |
| 25 | Linda DuskaUniversity of Virginia Health System, VA | 60 contributions |
Emerging
11 of the 427 carry the Emerging flag: publication and trial activity rising over the recent three years, in the top ten percent for growth among specialty peers at a similar career stage. Listed A to Z, not ranked; the flag is a yes or nothing, never a score. How the flag is computed.
| Ronald AlvarezVanderbilt University Medical Center, TN |
| Stephane ChampiatThe University of Texas MD Anderson Cancer Center, TX |
| Cathy EngVanderbilt University Medical Center, TN |
| Samir KhleifGeorgetown University School of Medicine, GA |
| Gottfried KonecnyUniversity of California, Los Angeles, CA |
| Wells MessersmithUniversity of Colorado Cancer Center, CO |
| Gregg NewmanSansum Medical Clinic, CA |
| Alessandro SantinYale School of Medicine, CT |
| Matthew SchwedeSwedish Medical Center, WA |
| Janos TanyiUniversity of Pennsylvania, PA |
| Apostolia TsimberidouThe University of Texas MD Anderson Cancer Center, TX |
How these tables are computed
The cohort is every profile in the directory tagged to Ovarian / Gynecologic Cancer, from the person's registered trials and published research. Only indications with at least 200 tagged people get a page; a smaller cohort would say more about the tag than about the people in it. Each table sorts the cohort by one count, highest first, with no weighting, no blending and no editorial pass. Ties are broken by the profile's stable internal id so the same counts always give the same order. A person with no count on record is left out of that table, not ranked last.
Citations, NIH awards and congress contributions are counts over a person's whole record, not their work in this indication alone, so those three tables are limited to the indication's investigators: people with at least 2 registered trials in it. Without that rule the most cited people in a cohort are the ones whose careers span many diseases, which is a fact about their careers, not about this field. The registered-trials table is the indication-scoped count itself and has no such limit.
The counts are recomputed on every publish and the page carries the date of the publish it was built from. Previous editions are superseded, not archived.
What is deliberately absent
Reported industry payments are on every profile but are not a table here: a count of payers is a fact, and ranking people by it reads as a judgment. Prescribing volume is part of the paid workspace. The directory's influence tier is a judgment and never orders a public page. Sources and methodology.
Filter, sort and open every Ovarian / Gynecologic Cancer profile in the directory